Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-24 @ 6:59 PM
NCT ID:
NCT01661257
Eligibility Criteria:
Inclusion Criteria:
* •Pediatric patients who were diagnosed with severe Crohn's disease who require infliximab treatment
* confirmed diagnostic of Crohn's disease in clinical, endoscopic and histological findings
Exclusion Criteria:
* •patients who has proven to have infliximab antibody
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
13 Years
Maximum Age:
17 Years
Study:
NCT01661257
Study Brief:
Protocol Section:
NCT01661257